# Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.

> **NCT04664985** · NA · UNKNOWN · sponsor: **Laboratoires IPRAD** · enrollment: 80 (estimated)

## Conditions studied

- Vaginal Disease

## Interventions

- **DEVICE:** Mucogyne® ovule

## Key facts

- **NCT ID:** NCT04664985
- **Lead sponsor:** Laboratoires IPRAD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10-06
- **Primary completion:** 2022-08-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-01-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04664985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04664985, "Evaluation of Mucogyne® Ovule in Vulvovaginal Dryness Management in Women Treated by Brachytherapy and/or Radiotherapy for Endometrial or Cervical Cancer.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04664985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
